Earningsreport

Q2/2021 6/30/2021 EPS 0.060 ZacksConsensus -0.400 ActVsEst 0.460 - Beat

Redhill Biopharma Ltd. - American Depositary Shares  (RDHL) 
US:NASDAQ Investor Relations: ir.redhillbio.com/investor-relations